Data Sharing Goes Linux

A life-science information platform joins the nonprofit organization that helped develop the open-source operating system.

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, W.REBELThe Biological Expression Language (BEL) may be on the road to becoming a ubiquitous mode of communication among life scientists. OpenBEL, the open-source software project that seeks to transform life science data into something akin to HTML coding language, has partnered with The Linux Foundation, the nonprofit technology consortium that promotes the growth and development of the open-source operating system Linux.

The marriage should provide a boost to OpenBEL, which is already used by many in industry and academia to enable better collaboration on big data projects, such as drug development. The hope is that the nonprofit can do for OpenBEL what it is doing for Linux, which has become lingua franca among collaborative software developers and hackers alike.

“All of us are smarter collectively than any one of us is by ourselves, and Linux is one of the greatest examples of that principle,” said Jim Zemlin, executive director at The Linux Foundation, in a statement. “OpenBEL represents an amazing opportunity for openness and collaboration to advance science, and we’re happy to impart our knowledge of collaborative software development to leaders in the life sciences industry.”

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies